BRD4 and cancer: Phosphorylation of BRD4 (pBRD4) is often associated with enhanced BRD4 oncogenic activities in cancer, as demonstrated by hyper-phosphorylated BRD4 in NUT midline carcinoma, potentially mediated by CDK9 (Wang et al., 2017).